← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2007First marketed drug
Jan 1, 2005First NDA
Apr 28, 2017Last known activity
Jan 31, 2023
Timeline
1990s
- Sep 6, 1991
sulindac— Marketing Organization
2000s
- Jan 1, 2005
Radius Health— Founded
2010s
- Apr 28, 2017
abaloparatide— NDA Organization
Drugs by trial phase (7 distinct, 21 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (2)
Recent trials (27)
- NCT05387798Lead sponsorPhase 3Jan 31, 2023
- NCT05098509Lead sponsorPhase 2/Phase 3Jan 3, 2022
- NCT04797728CollaboratorEarly Phase 1May 9, 2021
- NCT04626141CollaboratorPhase 4Jan 31, 2021
- NCT04936984Lead sponsorPhase 1Nov 16, 2020
- NCT04663464Lead sponsorPhase 1Nov 16, 2020
- NCT04467983CollaboratorPhase 4Aug 1, 2020
- NCT04064411Lead sponsorPhase 3Aug 5, 2019
- NCT04366726Lead sponsorPhase 1Apr 9, 2019
- NCT03778931Lead sponsorPhase 3Nov 20, 2018
- NCT03778931Study directorPhase 3Nov 20, 2018
- NCT03710889Lead sponsorPhase 3Sep 20, 2018
- NCT03710889Study directorPhase 3Sep 20, 2018
- NCT03512262Study directorPhase 3Mar 30, 2018
- NCT03512262Lead sponsorPhase 3Mar 30, 2018
Details
- Founded
- Waltham, MA, US Jan 1, 2005
- First NDA
- Apr 28, 2017
- Last known activity
- Jan 31, 2023